STOCK TITAN

Medtronic (MDT) Chief Accounting Officer reports bona fide gift of 340 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medtronic plc Chief Accounting Officer Denise L. Blomquist reported a bona fide gift of 340 Ordinary Shares of Medtronic on February 20, 2026. The gift was reported at a price of $0.00 per share, indicating no consideration was received for the transfer.

Following this charitable or personal gift transaction, Blomquist’s directly held stake stands at 11,966 Ordinary Shares of Medtronic. The filing reflects a disposition of shares through gifting rather than an open-market sale or purchase.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blomquist Denise L.

(Last) (First) (Middle)
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MN 55432

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 02/20/2026 G 340 D $0 11,966 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Medtronic (MDT) report for Denise L. Blomquist?

Medtronic’s Chief Accounting Officer Denise L. Blomquist reported a bona fide gift of 340 Ordinary Shares. The transaction is classified as a non-derivative disposition, reflecting a transfer of shares by gift rather than a market sale or purchase.

How many Medtronic (MDT) shares did Denise L. Blomquist gift?

Denise L. Blomquist gifted 340 Ordinary Shares of Medtronic. This transfer was reported with a transaction code G, indicating a bona fide gift, and was recorded as a non-derivative disposition at a reported price of $0.00 per share.

What is Denise L. Blomquist’s Medtronic (MDT) shareholding after the gift?

After the reported gift of 340 Ordinary Shares, Denise L. Blomquist directly holds 11,966 Medtronic shares. This post-transaction balance reflects only her directly reported ownership and follows the single bona fide gift transaction disclosed in the Form 4.

Did Medtronic (MDT) Chief Accounting Officer sell shares in this Form 4?

The Form 4 does not show a sale; it reports a bona fide gift. Denise L. Blomquist disposed of 340 Ordinary Shares through a gift transaction, recorded with code G, rather than through an open-market or privately negotiated sale of shares.

What does transaction code G mean in the Medtronic (MDT) Form 4 filing?

Transaction code G in the Medtronic Form 4 indicates a bona fide gift. In this case, it reflects Denise L. Blomquist’s disposition of 340 Ordinary Shares via a gift, with no price paid per share and no buy or sell classification.

Is the Medtronic (MDT) Form 4 transaction by Denise L. Blomquist direct or indirect ownership?

The Form 4 classifies Denise L. Blomquist’s ownership as direct. The 340-share gift and the remaining 11,966 Ordinary Shares are reported under direct ownership, with no separate entity or indirect ownership structure indicated in the provided data.
Medtronic

NYSE:MDT

MDT Rankings

MDT Latest News

MDT Latest SEC Filings

MDT Stock Data

126.42B
1.28B
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
Ireland
GALWAY